The risk and predictors for severe radiation pneumonitis in lung cancer patients treated with thoracic reirradiation

[1]  C. Simone,et al.  Systematic assessment of clinical outcomes and toxicities of proton radiotherapy for reirradiation. , 2017, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[2]  Toshiaki Takahashi,et al.  Re-irradiation for locoregionally recurrent tumors of the thorax: a single-institution, retrospective study , 2016, Radiation Oncology.

[3]  N. Dunlap,et al.  Stereotactic Body Radiation Therapy as Salvage for Intrathoracic Recurrence in Patients With Previously Irradiated Locally Advanced Non–Small Cell Lung Cancer , 2016, American journal of clinical oncology.

[4]  L. Livi,et al.  Available evidence on re-irradiation with stereotactic ablative radiotherapy following high-dose previous thoracic radiotherapy for lung malignancies. , 2015, Cancer Treatment Reviews.

[5]  Corinne Faivre-Finn,et al.  High-dose re-irradiation following radical radiotherapy for non-small-cell lung cancer. , 2014, The Lancet. Oncology.

[6]  A. Del Conte,et al.  Clinical Investigation : Thoracic Cancer Stereotactic Body Radiation Therapy for Re-irradiation of Persistent or Recurrent Non-Small Cell Lung Cancer , 2014 .

[7]  Max Dahele,et al.  High-dose, conventionally fractionated thoracic reirradiation for lung tumors. , 2014, Lung cancer.

[8]  M. Mehta,et al.  Reirradiation for Locoregionally Recurrent Lung Cancer: Outcomes in Small Cell and Non–Small Cell Lung Carcinoma , 2014, American journal of clinical oncology.

[9]  D. de Ruysscher,et al.  Early and locally advanced non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. , 2013, Annals of oncology : official journal of the European Society for Medical Oncology.

[10]  E. Yorke,et al.  Toxicity and outcomes of thoracic re-irradiation using stereotactic body radiation therapy (SBRT) , 2013, Radiation oncology.

[11]  Suresh Senan,et al.  Comparing rigid and deformable dose registration for high dose thoracic re-irradiation. , 2013, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[12]  Joe Y. Chang,et al.  Predicting radiation pneumonitis after stereotactic ablative radiation therapy in patients previously treated with conventional thoracic radiation therapy. , 2012, International journal of radiation oncology, biology, physics.

[13]  Joe Y. Chang,et al.  Stereotactic body radiation therapy for patients with lung cancer previously treated with thoracic radiation. , 2010, International journal of radiation oncology, biology, physics.

[14]  Y. Korogi,et al.  Re-irradiation Plus Regional Hyperthermia for Recurrent Non-small Cell Lung Cancer , 2010 .

[15]  M. Anscher,et al.  Radiation pulmonary toxicity: from mechanisms to management. , 2010, Seminars in radiation oncology.

[16]  R. Govindan,et al.  Definitive chemoradiation for the treatment of locally advanced non small-cell lung cancer. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[17]  Vladimir Pekar,et al.  Assessment of a model-based deformable image registration approach for radiation therapy planning. , 2007, International journal of radiation oncology, biology, physics.

[18]  R. Loddenkemper,et al.  Weekly docetaxel as second-line chemotherapy in advanced non-small cell lung cancer: phase II trial. , 2004, Anticancer research.

[19]  G. Jiang,et al.  Three-dimensional conformal radiotherapy for locoregionally recurrent lung carcinoma after external beam irradiation: a prospective phase I-II clinical trial. , 2003, International journal of radiation oncology, biology, physics.

[20]  A. Brugarolas,et al.  Second-Line Chemotherapy With Irinotecan and Vinorelbine in Stage IIIB and IV Non–Small-Cell Lung Cancer: A Phase II Study , 2002, American journal of clinical oncology.

[21]  M. Socinski,et al.  Second‐line, low‐dose, weekly paclitaxel in patients with stage IIIB/IV nonsmall cell lung carcinoma who fail first‐line chemotherapy with carboplatin plus paclitaxel , 2002, Cancer.

[22]  T. Nakajima,et al.  Reirradiation for locally recurrent lung cancer previously treated with radiation therapy. , 2002, International journal of radiation oncology, biology, physics.